Join a comprehensive medical presentation where Dr. Michael Miedema debunks five common misconceptions about obesity and modern weight loss medications. Explore the latest research and clinical insights on GLP-1 agonists, addressing their effectiveness, safety, and role in treating both obesity and cardiovascular disease. Learn about the scientific evidence behind these medications, understand their true relationship with lifestyle modifications, and get clarity on concerns regarding side effects and costs. Gain valuable knowledge about the current obesity epidemic affecting more than 42% of adults in the United States, and discover how healthcare providers are responding to increased patient interest in prescription weight loss treatments. Conclude with an informative question and answer session that further clarifies these important medical developments.